Key result
Resveratrol significantly improved the meiotic maturation rate of doxorubicin-treated mouse oocytes from 35.93% to 48.20% by reducing oxidative stress and apoptosis.
Why the study?
The underlying mechanisms of doxorubicin exposure on female fertility and strategies to prevent it have not been well studied.
Does resveratrol prevent doxorubicin-induced meiotic failure and apoptosis in mouse oocytes?
Does resveratrol prevent doxorubicin-induced meiotic failure and apoptosis in mouse oocytes?
Absolute Event Rate: 48.2% vs 35.93%
p-value: p=<0.01
Resveratrol protects mouse oocytes against doxorubicin-induced oxidative stress and apoptosis, suggesting a potential strategy to preserve female fertility during chemotherapy.
Hypothesis-generating for resveratrol in oocyte protection during chemotherapy; human trials required before any fertility practice change.
Doxorubicin (DXR), a widely used chemotherapeutic drug, has adverse effects on female fertility in young cancer patients. However, the underlying mechanisms of doxorubicin exposure on female fertility and how to prevent it have not been well studied yet. Here, mouse oocytes were employed to investigate the issues mentioned above. The results showed that doxorubicin treatment impaired oocyte meiotic maturation by destroying spindle assembly and chromosome arrangement. In addition, doxorubicin caused oxidative stress by increasing reactive oxygen species (ROS) levels. Furthermore, doxorubicin led to severe DNA damage in oocytes, which eventually induced apoptosis through DNA damage-P63-Caspase3 pathway. Conversely, resveratrol (RES) effectively improved oocyte quality by restoring spindle and chromosome configuration, reducing ROS levels and inhibiting apoptosis. In summary, our results indicate that RES can protect oocytes against doxorubicin-induced damage.
No takes yet. Share an insight, caveat, or question.
Han et al. (2020) studied Doxorubicin-induced meiotic failure in oocytes. Resveratrol vs. Doxorubicin (200 nM) alone was evaluated on Oocyte meiotic maturation rate (first polar body extrusion) (p=<0.01). Resveratrol significantly improved the meiotic maturation rate of doxorubicin-treated mouse oocytes from 35.93% to 48.20% by reducing oxidative stress and apoptosis.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: